Literature DB >> 11764093

Hypothalamic lesions in multiple sclerosis.

I Huitinga1, C J De Groot, P Van der Valk, W Kamphorst, F J Tilders, D F Swaab.   

Abstract

Demyelinating lesions of fiber bundles in and adjacent to the hypothalamus (i.e. the fornix. anterior commissure, internal capsule, and optic system) may be the basis for autonomic and endocrine alterations in multiple sclerosis (MS) patients. Therefore we investigated the presence and immunological activity of lesions in hypothalamic fiber bundles of 17 MS patients and 14 controls. In the MS group, 16 of 17 patients showed demyelinated lesions. The incidence of active lesions was high (60%) and outnumbered chronic inactive lesions in the internal capsule (p = 0.005). In 4 of 17 MS patients, axonal damage was observed and in 3 of 17 MS patients grey matter lesions were apparent. Duration of MS was inversely related to the active hypothalamic MS lesion score (r = -0.72, p = 0.001). Since comparison of hypothalamic lesions with MS lesions in other areas of the brain in the same patients (n = 7) showed a great similarity both as stage and appearance was concerned, this negative relation in all likelihood reflects the clinical consequences of high disease activity throughout the whole brain. In controls no demyelinating lesions were seen but in 11 control cases HLA expression was observed that was lower than that present in MS patients (p = 0.02). In the median eminence region that lacks a blood-brain barrier, all controls showed a strong HLA expression around the blood vessels. We conclude that systematic pathological investigation of the hypothalamus in MS patients reveals an unexpected high incidence of active lesions that may impact on hypothalamic functioning.

Entities:  

Mesh:

Year:  2001        PMID: 11764093     DOI: 10.1093/jnen/60.12.1208

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  23 in total

1.  Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms.

Authors:  Stefan M Gold; Kyle C Kern; Mary-Frances O'Connor; Michael J Montag; Aileen Kim; Ye S Yoo; Barbara S Giesser; Nancy L Sicotte
Journal:  Biol Psychiatry       Date:  2010-06-19       Impact factor: 13.382

Review 2.  Thermoregulation in multiple sclerosis.

Authors:  Scott L Davis; Thad E Wilson; Andrea T White; Elliot M Frohman
Journal:  J Appl Physiol (1985)       Date:  2010-07-29

Review 3.  Autonomic dysfunction, immune regulation, and multiple sclerosis.

Authors:  Juan Manuel Racosta; Kurt Kimpinski
Journal:  Clin Auton Res       Date:  2015-12-21       Impact factor: 4.435

Review 4.  Grey matter damage in multiple sclerosis: a pathology perspective.

Authors:  Roel Klaver; Helga E De Vries; Geert J Schenk; Jeroen J G Geurts
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

Review 5.  Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation.

Authors:  Kevin G Burfeind; Vijayshree Yadav; Daniel L Marks
Journal:  Curr Neurol Neurosci Rep       Date:  2016-11       Impact factor: 5.081

6.  Multi-contrast, isotropic, single-slab 3D MR imaging in multiple sclerosis.

Authors:  Bastiaan Moraal; Stefan D Roosendaal; Petra J W Pouwels; Hugo Vrenken; Ronald A van Schijndel; Dominik S Meier; Charles R G Guttmann; Jeroen J G Geurts; Frederik Barkhof
Journal:  Eur Radiol       Date:  2008-05-29       Impact factor: 5.315

7.  Regional grey matter atrophy in clinically isolated syndromes at presentation.

Authors:  R G Henry; M Shieh; D T Okuda; A Evangelista; M L Gorno-Tempini; D Pelletier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-05-09       Impact factor: 10.154

8.  Deep gray matter and fatigue in MS: a T1 relaxation time study.

Authors:  G Niepel; Ch R Tench; P S Morgan; N Evangelou; D P Auer; C S Constantinescu
Journal:  J Neurol       Date:  2006-03-13       Impact factor: 4.849

Review 9.  Temperature sensitivity in multiple sclerosis: An overview of its impact on sensory and cognitive symptoms.

Authors:  Aikaterini Christogianni; Richard Bibb; Scott L Davis; Ollie Jay; Michael Barnett; Nikos Evangelou; Davide Filingeri
Journal:  Temperature (Austin)       Date:  2018-09-05

10.  Assessment of autonomic nervous system dysfunction in multiple sclerosis and association with clinical disability.

Authors:  Nilufer Kale; Setty Magana; Jale Agaoglu; Osman Tanik
Journal:  Neurol Int       Date:  2009-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.